Lysosomal beta Glucuronidase [EPC]

Lysosomal beta Glucuronidase [EPC] was reported 64 times

Drugs of the Lysosomal beta Glucuronidase [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIAC VALVE THICKENING 1 0.0169
1 MYIASIS 1 0.0161
2 INFUSION SITE PAPULE 1 0.0105
3 STATUS ASTHMATICUS 2 0.0042
4 TRACHEAL HAEMORRHAGE 1 0.0028
5 NASAL TURBINATE HYPERTROPHY 1 0.0027
6 OTITIS MEDIA CHRONIC 1 0.0024
7 INFUSION SITE VESICLES 1 0.0019
8 INFUSION SITE URTICARIA 1 0.0015
9 PRURIGO 1 0.0011
10 FRACTURED COCCYX 1 0.0008
11 CORNEAL OPACITY 1 0.0007
12 ABSCESS ORAL 1 0.0007
13 RHONCHI 1 0.0007
14 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
15 INAPPROPRIATE AFFECT 1 0.0006
16 TONSILLECTOMY 1 0.0006
17 SPINAL DEFORMITY 1 0.0006
18 NASAL OBSTRUCTION 1 0.0005
19 RHINOVIRUS INFECTION 2 0.0005
20 SPINAL CORD COMPRESSION 2 0.0005
21 EAR SWELLING 1 0.0005
22 MIDDLE EAR EFFUSION 1 0.0005
23 BACTERIAL TEST POSITIVE 1 0.0004
24 RADIUS FRACTURE 1 0.0004
25 CLONUS 1 0.0004
26 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
27 HYPERCAPNIA 1 0.0003
28 GRANULOMA 1 0.0003
29 ABSCESS LIMB 1 0.0002
30 HYPOVOLAEMIC SHOCK 1 0.0002
31 PETIT MAL EPILEPSY 1 0.0002
32 BEHAVIOUR DISORDER 1 0.0002
33 HIP SURGERY 1 0.0002
34 SKIN INFECTION 2 0.0002
35 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
36 PULMONARY HAEMORRHAGE 1 0.0001
37 ACUTE RESPIRATORY FAILURE 2 0.0001
38 HYPOTHERMIA 1 0.0001
39 POOR VENOUS ACCESS 1 0.0001
40 JOINT DISLOCATION 1 0.0001
41 PHARYNGITIS STREPTOCOCCAL 1 0.0001
42 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
43 POST PROCEDURAL HAEMORRHAGE 1 0.0001
44 SMALL INTESTINAL OBSTRUCTION 1 0.0001
45 PHARYNGITIS 1 0.0001
46 SECRETION DISCHARGE 1 0.0001
47 RESPIRATORY TRACT INFECTION 2 0.0001
48 DEVICE OCCLUSION 1 0.0001
49 HEAD INJURY 2 0.0001
50 FACE OEDEMA 1 0.0001
51 CHOKING 1 0.0001
52 PRODUCT ADMINISTRATION ERROR 1 0.0000
53 BODY TEMPERATURE INCREASED 1 0.0000
54 RETCHING 1 0.0000
55 SNEEZING 1 0.0000
56 RESPIRATORY FAILURE 3 0.0000
57 THROAT TIGHTNESS 1 0.0000
58 PALLOR 1 0.0000
59 PNEUMONITIS 1 0.0000
60 SKIN LESION 1 0.0000
61 ANAPHYLACTIC REACTION 2 0.0000
62 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
63 INTENTIONAL DOSE OMISSION 1 0.0000
64 ASCITES 1 0.0000
65 NERVOUS SYSTEM DISORDER 1 0.0000
66 INFUSION RELATED REACTION 2 0.0000
67 CRYING 1 0.0000
68 INTESTINAL OBSTRUCTION 1 0.0000
69 ABNORMAL BEHAVIOUR 1 0.0000
70 NEUTROPHIL COUNT DECREASED 1 0.0000
71 CARDIO-RESPIRATORY ARREST 1 0.0000
72 PULMONARY OEDEMA 1 0.0000
73 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
74 SWELLING 2 0.0000
75 PULMONARY EMBOLISM 2 0.0000
76 CONTUSION 2 0.0000
77 HYPOGLYCAEMIA 1 0.0000
78 CELLULITIS 1 0.0000
79 BRADYCARDIA 1 0.0000
80 MEDICATION ERROR 1 0.0000
81 PRODUCT DOSE OMISSION ISSUE 5 0.0000
82 IRRITABILITY 1 0.0000
83 RHINORRHOEA 1 0.0000
84 SWELLING FACE 1 0.0000
85 BLOOD PRESSURE DECREASED 1 0.0000
86 COUGH 4 0.0000
87 THERAPY INTERRUPTED 1 0.0000
88 CARDIAC FAILURE 1 0.0000
89 INFLUENZA LIKE ILLNESS 1 0.0000
90 CARDIAC ARREST 1 0.0000
91 URTICARIA 2 0.0000
92 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
93 NASOPHARYNGITIS 2 0.0000
94 OROPHARYNGEAL PAIN 1 0.0000
95 VOMITING 5 0.0000
96 ILLNESS 1 0.0000
97 ABDOMINAL DISTENSION 1 0.0000
98 PNEUMONIA 3 0.0000
99 RASH 4 0.0000
100 FALL 3 0.0000
101 DEHYDRATION 1 0.0000
102 NEUTROPENIA 1 0.0000
103 ACUTE KIDNEY INJURY 1 0.0000
104 HOSPITALISATION 1 0.0000
105 DRUG INTERACTION 1 0.0000
106 TREMOR 1 0.0000
107 ABDOMINAL DISCOMFORT 1 0.0000
108 URINARY TRACT INFECTION 1 0.0000
109 PYREXIA 2 0.0000
110 COVID-19 1 0.0000
111 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
112 HYPERSENSITIVITY 1 0.0000
113 PRODUCT USE ISSUE 1 0.0000
114 HYPOTENSION 1 0.0000
115 SOMNOLENCE 1 0.0000
116 HYPERTENSION 1 0.0000
117 WEIGHT INCREASED 1 0.0000
118 INCORRECT DOSE ADMINISTERED 1 0.0000
119 DECREASED APPETITE 1 0.0000
120 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
121 PRURITUS 1 0.0000
122 FATIGUE 2 0.0000
123 MALAISE 1 0.0000
124 DYSPNOEA 1 0.0000
125 PAIN 1 0.0000
126 DIARRHOEA 1 0.0000